In Vitro Modulation of TrkB Receptor Signaling upon Sequential Delivery of Curcumin-DHA Loaded Carriers Towards Promoting Neuronal Survival (Q48136178)

9 February 2018

title

In Vitro Modulation of TrkB Receptor Signaling upon Sequential Delivery of Curcumin-DHA Loaded Carriers Towards Promoting Neuronal Survival (English)

1 reference

9 February 2018

0 references

Angelina Angelova

1 reference

9 February 2018

Luis P B Guerzoni

1 reference

9 February 2018

Valérie Nicolas

series ordinal

1 reference

9 February 2018

publication date

19 December 2016

1 reference

9 February 2018

published in

Pharmaceutical Research

1 reference

9 February 2018

volume

1 reference

9 February 2018

issue

1 reference

9 February 2018

page(s)

492-505

1 reference

9 February 2018

Spreading of pathology in neurodegenerative diseases: a focus on human studies

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Neurotrophins and their receptors: a convergence point for many signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Synaptic therapy in Alzheimer's disease: a CREB-centric approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

CREB expression mediates amyloid β-induced basal BDNF downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Delivery of brain-derived neurotrophic factor via nose-to-brain pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Why neurons die: cell death in the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Brain Derived Neurotrophic Factor: a novel neurotrophin involved in psychiatric and neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Potential therapeutic uses of BDNF in neurological and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Neurotrophin-regulated signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

The structures of the neurotrophin 4 homodimer and the brain-derived neurotrophic factor/neurotrophin 4 heterodimer reveal a common Trk-binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Using polymer chemistry to modulate the delivery of neurotrophic factors from degradable microspheres: delivery of BDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

In-depth quantitative proteomic analysis of de novo protein synthesis induced by brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

BDNF stimulation of protein synthesis in cortical neurons requires the MAP kinase-interacting kinase MNK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Brain-derived neurotrophic factor in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Pathways towards and away from Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Repairing the parkinsonian brain with neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Neurotrophin delivery using nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

CREB: a major mediator of neuronal neurotrophin responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Enhanced CREB phosphorylation in immature dentate gyrus granule cells precedes neurotrophin expression and indicates a specific role of CREB in granule cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Self-amplified BDNF transcription is a regulatory system for synaptic maturation in cultured cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

CREB: a multifaceted regulator of neuronal plasticity and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

BDNF increases with behavioral enrichment and an antioxidant diet in the aged dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Flavonoids and cognition: the molecular mechanisms underlying their behavioural effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Activation of Trk neurotrophin receptors in the absence of neurotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Natural extracts as possible protective agents of brain aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Phenolics as potential antioxidant therapeutic agents: mechanism and actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Neuronal Uptake and Neuroprotective Properties of Curcumin-Loaded Nanoparticles on SK-N-SH Cell Line: Role of Poly(lactide-co-glycolide) Polymeric Matrix Composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Biochemical and biophysical investigation of the brain-derived neurotrophic factor mimetic 7,8-dihydroxyflavone in the binding and activation of the TrkB receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

7,8-Dihydroxyflavone as a pro-neurotrophic treatment for neurodevelopmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Neuroprotective potential of phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Novel antioxidants protect mitochondria from the effects of oligomeric amyloid beta and contribute to the maintenance of epigenome function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Antioxidant vitamin intake and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Eicosapentaenoic acid (EPA) increases cell viability and expression of neurotrophin receptors in retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Brain-derived neurotrophic factor and neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

BDNF-induced local protein synthesis and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Shaping neurons: Long and short range effects of mature and proBDNF signalling upon neuronal structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

A novel small Odorranalectin-bearing cubosomes: preparation, brain delivery and pharmacodynamic study on amyloid-β₂₅₋₃₅-treated rats following intranasal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Neurotherapeutic applications of nanoparticles in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Lipid-based nanocarriers for CNS-targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Nanotechnological advances for the delivery of CNS therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Cubic membranes: a structure-based design for DNA uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

DNA/Fusogenic Lipid Nanocarrier Assembly: Millisecond Structural Dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Non-viral gene therapy for neurological diseases, with an emphasis on targeted gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Nanoparticles for direct nose-to-brain delivery of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Protein entrapment in PEGylated lipid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Curcumin containing monoolein aqueous dispersions: a preformulative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Earliest stage of the tetrahedral nanochannel formation in cubosome particles from unilamellar nanovesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Identification of large channels in cationic PEGylated cubosome nanoparticles by synchrotron radiation SAXS and Cryo-TEM imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Cubic phase nanoparticles (Cubosome): principles for controlling size, structure, and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

STED microscopy of living cells--new frontiers in membrane and neurobiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Statistical analysis of high-resolution light microscope images reveals effects of cytoskeleton-disrupting drugs on the membrane organization of the nicotinic acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

Validation of an Ultraviolet–visible (UV–Vis) technique for the quantitative determination of curcumin in poly(l-lactic acid) nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-016-2080-4

The expanding role of BDNF: a therapeutic target for Alzheimer's disease?

21 January 2018

1 reference

12 December 2020

Protein driven patterning of self-assembled cubosomic nanostructures: long oriented nanoridges

1 reference

12 December 2020

Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design

1 reference

12 December 2020

Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes

1 reference

12 December 2020

Brain-derived neurotrophic factor stimulates AP-1 and cyclic AMP-responsive element dependent transcriptional activity in central nervous system neurons.

1 reference

12 December 2020

Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal

1 reference

12 December 2020

Distribution of nerve growth factor following direct delivery to brain interstitium

1 reference

12 December 2020

Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease.

1 reference

12 December 2020

Withdrawal of BDNF from hippocampal cultures leads to changes in genes involved in synaptic function

1 reference

12 December 2020

The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.

1 reference

12 December 2020

Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells

1 reference

12 December 2020

Transactivation of Trk receptors in spinal motor neurons

1 reference

12 December 2020

10.1007/S11095-016-2080-4

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018